Document Type

Article

Publication Date

12-1-2021

Publication Title

Infectious disease clinics of North America

Abstract

Invasive fungal infections are an important cause of morbidity and mortality in hospitalized patients and in the immunocompromised population. This article reviews the current epidemiology of nosocomial fungal infections in adult patients, with an emphasis on invasive candidiasis (IC) and invasive aspergillosis (IA). Included are descriptions of nosocomial infections caused by Candida auris, an emerging pathogen, and IC- and IA-associated with coronavirus disease 2019. The characteristics and availability of newer nonculture-based tests for identification of nosocomial fungal pathogens are discussed. Recently published recommendations and guidelines for the control and prevention of these nosocomial fungal infections are summarized.

Medical Subject Headings

Antifungal Agents; COVID-19; Cross Infection; Fungi; Humans; Immunocompromised Host; Infection Control; Mycoses; Risk Factors; SARS-CoV-2

PubMed ID

34752219

Volume

35

Issue

4

First Page

1027

Last Page

1053

Share

COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.